Brookline, MA, United States of America

Peter Viski



 

Average Co-Inventor Count = 7.3

ph-index = 5

Forward Citations = 317(Granted Patents)


Location History:

  • Brookline, MA (US) (2004 - 2013)
  • Asharoken, NY (US) (2008 - 2015)

Company Filing History:

goldMedal9 out of 71 
 
Paratek Pharmaceuticals, Inc.
 patents
silverMedal4 out of 459 
 
Tufts College
 patents
bronzeMedal1 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 2004-2015

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Peter Viski: A Trailblazer in Tetracycline Compounds

Introduction

Peter Viski is a distinguished inventor based in Brookline, MA, recognized for his significant contributions to the field of pharmaceutical innovations. With a remarkable portfolio of 10 patents, Viski has focused on developing novel compounds aimed at treating various medical conditions, showcasing his expertise in medicinal chemistry.

Latest Patents

Among his latest patents are the groundbreaking innovations related to minocycline and tetracycline compounds. His patent on "9-substituted minocycline compounds" includes novel formulations that address various tetracycline compound-responsive states, such as bacterial infections and neoplasms. These innovative compounds have the potential to not only treat infections but also help in blocking tetracycline efflux and modulating gene expression.

Similarly, his patent on "7-substituted tetracycline compounds" expands the scope of tetracycline applications, focusing on treatment options for bacterial infections and neoplasms. This invention reiterates the versatility and transformative potential of tetracycline derivatives in modern medicine.

Career Highlights

Peter Viski has had a fruitful career, notably working with Paratek Pharmaceuticals, Inc., where his research contributions played a vital role in advancing the pharmaceutical landscape. Additionally, his tenure at Tufts College has further solidified his reputation as a thought leader in medicinal chemistry and pharmacology.

Collaborations

Throughout his career, Viski has collaborated with prominent figures in medicine and science, including colleagues Mark L. Nelson and Beena Bhatia. These collaborations have fostered an environment of innovation, leading to the development of impactful therapies that address urgent health concerns.

Conclusion

Peter Viski's innovative work in the realm of tetracycline compounds stands as a testament to his commitment to advancing healthcare. With his extensive experience and collaborative spirit, Viski continues to make significant strides in pharmaceuticals, paving the way for future medical breakthroughs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…